Krynica Vitamin Statistics
Total Valuation
Krynica Vitamin has a market cap or net worth of PLN 151.91 million. The enterprise value is 178.11 million.
| Market Cap | 151.91M |
| Enterprise Value | 178.11M |
Important Dates
The last earnings date was Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Krynica Vitamin has 12.25 million shares outstanding.
| Current Share Class | 12.25M |
| Shares Outstanding | 12.25M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.62M |
Valuation Ratios
The trailing PE ratio is 12.71.
| PE Ratio | 12.71 |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 1.48 |
| P/TBV Ratio | 1.54 |
| P/FCF Ratio | 6.14 |
| P/OCF Ratio | 4.97 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.93, with an EV/FCF ratio of 7.20.
| EV / Earnings | 14.90 |
| EV / Sales | 0.50 |
| EV / EBITDA | 4.93 |
| EV / EBIT | 8.24 |
| EV / FCF | 7.20 |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.26.
| Current Ratio | 0.99 |
| Quick Ratio | 0.56 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 0.73 |
| Debt / FCF | 1.07 |
| Interest Coverage | 10.46 |
Financial Efficiency
Return on equity (ROE) is 12.15% and return on invested capital (ROIC) is 12.91%.
| Return on Equity (ROE) | 12.15% |
| Return on Assets (ROA) | 6.55% |
| Return on Invested Capital (ROIC) | 12.91% |
| Return on Capital Employed (ROCE) | 17.88% |
| Weighted Average Cost of Capital (WACC) | 4.59% |
| Revenue Per Employee | 1.02M |
| Profits Per Employee | 34,342 |
| Employee Count | 348 |
| Asset Turnover | 1.73 |
| Inventory Turnover | 8.59 |
Taxes
In the past 12 months, Krynica Vitamin has paid 2.88 million in taxes.
| Income Tax | 2.88M |
| Effective Tax Rate | 19.40% |
Stock Price Statistics
The stock price has increased by +37.78% in the last 52 weeks. The beta is 0.01, so Krynica Vitamin's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | +37.78% |
| 50-Day Moving Average | 11.36 |
| 200-Day Moving Average | 10.38 |
| Relative Strength Index (RSI) | 68.97 |
| Average Volume (20 Days) | 891 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Krynica Vitamin had revenue of PLN 356.27 million and earned 11.95 million in profits.
| Revenue | 356.27M |
| Gross Profit | 60.53M |
| Operating Income | 21.61M |
| Pretax Income | 14.83M |
| Net Income | 11.95M |
| EBITDA | 36.11M |
| EBIT | 21.61M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 307,000 in cash and 26.52 million in debt, with a net cash position of -26.21 million or -2.14 per share.
| Cash & Cash Equivalents | 307,000 |
| Total Debt | 26.52M |
| Net Cash | -26.21M |
| Net Cash Per Share | -2.14 |
| Equity (Book Value) | 102.66M |
| Book Value Per Share | n/a |
| Working Capital | -479,000 |
Cash Flow
In the last 12 months, operating cash flow was 30.54 million and capital expenditures -5.79 million, giving a free cash flow of 24.75 million.
| Operating Cash Flow | 30.54M |
| Capital Expenditures | -5.79M |
| Depreciation & Amortization | 14.50M |
| Net Borrowing | -19.55M |
| Free Cash Flow | 24.75M |
| FCF Per Share | 2.02 |
Margins
Gross margin is 16.99%, with operating and profit margins of 6.07% and 3.35%.
| Gross Margin | 16.99% |
| Operating Margin | 6.07% |
| Pretax Margin | 4.16% |
| Profit Margin | 3.35% |
| EBITDA Margin | 10.14% |
| EBIT Margin | 6.07% |
| FCF Margin | 6.95% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.18%.
| Dividend Per Share | 0.27 |
| Dividend Yield | 2.18% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 27.68% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.18% |
| Earnings Yield | 7.87% |
| FCF Yield | 16.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |